Perseus Proteomics Inc. Perseus Proteomics Inc.

Perseus Proteomics Inc.

4882

Rank in Stocks #27713
Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology... Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology venture specializing in the development of antibody-based therapeutics for various ailments, including cancer. Its core operations encompass pioneering antibody discovery, alongside providing extensive research support services. These services include hybridoma antibody sequencing, the production of antibody proteins, and undertaking contract antibody research projects. Furthermore, Perseus Proteomics supplies its own antibody products to the market. The company boasts a robust development pipeline featuring several promising candidates: PPMX-T001, an antibody targeting hepatocarcinoma; PPMX-T002, an oncology therapeutic; PPMX-T003, designed for the treatment of adult T-cell leukemia/lymphoma; and PPMX-T004, an innovative antibody-drug conjugate. Established in 2001, the firm maintains its headquarters in the Japanese capital.
Share Price
$0.78791117
Last synced: 2026-11-13
Market Cap
$13.47M
Change (1 day)
0.68%
Change (1 year)
-59.02%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Perseus Proteomics Inc. (4882)
Operating Margin as of November 2026 TTM: -496.49%
According to Perseus Proteomics Inc.'s latest financial reports, its current operating margin (TTM) is -496.49%. At the end of 2025 the company had an operating margin of -689.26%.
Operating Margin history for Perseus Proteomics Inc. from 2020 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -496.49% -27.97%
2025 -689.26% -22.65%
2024 -891.15% 20.31%
2023 -740.72% 12.84%
2022 -656.45% 8.33%
2021 -605.99% -36.56%
2020 -955.29% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
46.07% -100.09%
US
25.17% -100.05%
US
35.21% -100.07%
US
31.92% -100.06%
CH
13.64% -100.03%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Perseus Proteomics Inc.'s operating margin

What is Perseus Proteomics Inc.'s operating margin?

Perseus Proteomics Inc.'s operating margin is -496.49%, as of Nov 2026.

What was Perseus Proteomics Inc.'s operating margin in 2025?

In 2025, Perseus Proteomics Inc.'s operating margin was -689.26%, compared with -891.15% in 2024.

How has Perseus Proteomics Inc.'s operating margin changed since 2020?

From 2020 to 2025, Perseus Proteomics Inc.'s operating margin was highest in 2021 (-605.99%) and lowest in 2020 (-955.29%).

How does Perseus Proteomics Inc.'s operating margin compare with similar companies?

Perseus Proteomics Inc.'s operating margin (-496.49%) is lower than that of all 5 similar companies listed above. The highest among them is Eli Lilly and Company, with 46.07%.